| Sie befinden sich in - ||Home|| - ||Fachinformation zu gyno-Tardyferon®|
|Fachinformation zu gyno-Tardyferon®:||Pierre Fabre Pharma SA|
|B03AD03 - Ferrous Sulfate||ATC-DDD Version 2016. Source: WHO|
|B - Blood and Blood Forming Organs|
|B03 - Antianemic Preparations|
|B03AD - Iron in Combination with Folic Acid|
This group comprises iron in combination with folic acid. Preparations containing additional substances, see B03AE.
The DDDs have been based on prophylaxis of iron deficiency anemia and folic acid deficiency during pregnancy (i.e. about half the iron dose for treatment of anemia).
|B03AD03 - Ferrous Sulfate|